{"nct_id":"NCT03737643","title":"Durvalumab Treatment in Combination With Chemotherapy and Bevacizumab, Followed by Maintenance Durvalumab, Bevacizumab and Olaparib Treatment in Advanced Ovarian Cancer Patients","status":"ACTIVE_NOT_RECRUITING","status_verified_date":"2025-01","start_date":"2019-01-04","start_date_type":"ACTUAL","primary_completion_date":"2025-03-28","primary_completion_date_type":"ESTIMATED","completion_date":"2028-03-30","completion_date_type":"ESTIMATED","phases":["PHASE3"],"tickers":["AZN"]}